Try our Advanced Search for more refined results

Expert Analysis

How The FDA Can Compel Post-Marketing Studies

Law360 (April 29, 2011, 5:21 PM EDT) -- The U.S. Food and Drug Administration announced in the Federal Register on April 1 the availability of a draft guidance for industry titled "Post-Marketing Studies and Clinical Trials — Implementation of Section 505(o)(3) of the Federal Food, Drug and Cosmetic Act" (the draft guidance). Comments on the draft guidance may be submitted at any time....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!